We know what works to fight pneumonia in children. Improving access to prompt diagnosis and treatment of pneumonia and scaling up vaccines that protect children against particularly deadly strains has occurred in many countries. So why has progress against pneumonia fallen behind?
Biography
Nancy Fullman, MPH, is Scientific Advisor at the Institute for Health Metrics and Evaluation (IHME). In this role, she supports the generation, review, and publication of research results across multiple IHME projects. Nancy serves as a central point for implementing the highest possible scientific excellence throughout IHME, as well as advancing IHME’s overall scientific endeavors.
Previously, Nancy spent three years as one of IHME’s first Policy Translation Specialists, leading efforts to translate IHME’s research into actionable, policy-relevant materials and to engage stakeholders around the uses of global health evidence in decision-making. She led policy translation activities for the Access, Bottlenecks, Costs, and Equity (ABCE) project, a multicountry research initiative that assesses drivers of health system performance, and the Malaria Control Policy Assessment (MCPA) project in Zambia and Uganda. As a Policy Translation Specialist, Nancy also produced a pneumonia-focused report and supported work related to the Disease Control Priorities Network (DCPN) study, impact evaluations such as the Gavi Full Country Evaluations (FCE), and subnational benchmarking analyses in Nigeria.
Nancy was a Post-Bachelor Fellow at IHME from 2008 to 2011, during which time she conducted research on malaria interventions and helped launch the MCPA project in Zambia. She received her Master of Public Health in Health Metrics and Evaluation from the University of Washington in 2011. She then spent a year working for the University of California, San Francisco (UCSF) Global Health Group’s Malaria Elimination Initiative, where she led communications and advocacy efforts on behalf of malaria-eliminating countries, before returning to IHME in 2013.
Originally from a small town in New York State, Nancy received her bachelor’s degree in Psychology from Middlebury College.
Global Burden of Disease 2021 Health Financing Collaborator Network. Global investments in pandemic preparedness and COVID-19: tracking development assistance and domestic spending on health between 1990 and 2026. The Lancet Global Health. 24 January 2023. doi: 10.1016/S2214-109X(23)00007-4.
Global Burden of Disease Long COVID Collaborators. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 10 October 2022. doi: 10.1001/jama.2022.18931.
GBD 2019 Healthcare Access and Quality Collaborators. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet Global Health. 6 October 2022. doi: 10.1016/S2214-109X(22)00429-6.
Haakenstad A, Angelino O, Irvine CMS, et al. Measuring contraceptive method mix, prevalence, and demand satisfied by age and marital status in 204 countries and territories, 1970–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 21 July 2022. doi: 10.1016/S0140-6736(22)00936-9.
Flor LS, Wilson S, Wildes Amorim W, et al. Endline assessment of a community-based program on hypertension and diabetes management in Brazil. MedRxiv. 25 May 2022. doi: 10.1101/2022.05.22.22275385.
GBD 2019 Human Resources for Health Collaborators. Measuring the availability of human resources for health and its relationship to universal health coverage: estimates for 204 countries and territories from 1990 to 2019. The Lancet. 23 May 2022. doi: 10.1016/S0140-6736(22)00532-3.
COVID-19 Cumulative Infection Collaborators. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. The Lancet. 8 April 2022. doi: 10.1016/S0140-6736(22)00484-6.
COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. The Lancet. 10 March 2022. doi: 10.1016/S0140-6736(21)02796-3.
COVID-19 Forecasting Team. Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. The Lancet. 24 February 2022. doi: 10.1016/S0140-6736(21)02867-1.
COVID-19 National Preparedness Collaborators. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021. The Lancet. 1 February 2022. doi:10.1016/S0140-6736(22)00172-6.
Global Burden of Disease 2020 Health Financing Collaborator Network. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050. The Lancet. 22 September 2021. doi: 10.1016/S0140-6736(21)01258-7.
Fullman N, Cowling K, Flor LS, et al. Assessing the impact of community-based interventions on hypertension and diabetes management in three Minnesota communities: findings from the prospective evaluation of US HealthRise programs. MedRxiv. 29 August 2021. doi: 10.1101/2021.08.26.21262688.
Causey K, Fullman N, Sorensen RJD, Galles NC, Zheng P, Aravkin A, Danovaro-Holliday MC, Martinez-Piedra R, Sodha SV, Velandia-Gonzalez MP, Gacic-Dobo M, Castro E, He J, Schipp M, Deen A, Hay SI, Lim SS, Mosser JF. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study. The Lancet. 15 July 2021. doi: 10.1016/S0140-6736(21)01337-4.
GBD 2020, Release 1, Vaccine Coverage Collaborators. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1. The Lancet. 14 July 2021. doi: 10.1016/S0140-6736(21)00984-3.
Weaver MR, Nandakumar V, Joffe J, Barber RM, Fullman N, Singh A, Sparks GW, Yearwood J, Lozano R, Murray CJL, Ngo D. Variation in Health Care Access and Quality Among US States and High-Income Countries With Universal Health Insurance Coverage. JAMA Network Open. 28 June 202 doi: 10.1001/jamanetworkopen.2021.14730.
Local Burden of Disease Vaccine Coverage Collaborators. Mapping routine measles vaccination in low- and middle-income countries. Nature. 16 December 2020. doi: 10.1038/s41586-020-03043-4.
Gutierrez JP, Agudelo-Botero M, Garcia-Saiso S, Zepeda-Tena C, Davila-Cervantes CA, Gonzalez-Robledo MC, Fullman N, Razo C, Hernandez-Prado B, Martinez G, Barquera S, Lozano R. Advances and challenges on the path toward the SDGs: subnational inequalities in Mexico, 1990–2017. BMJ Global Health. 29 October 2020. doi: 10.1136/bmjgh-2020-002382.
IHME COVID-19 Forecasting Team. Modeling COVID-19 scenarios for the United States. Nature Medicine. 23 October 2020. doi:10.1038/s41591-020-1132-9.
GBD 2019 Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 27 August 2020. doi:10.1016/S0140-6736(20)30750-9.
Global Burden of Disease Health Financing Collaborator Network. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3. The Lancet. 23 April 2020. doi:10.1016/S0140-6736(20)30608-5.
Flor LS, Wilson S, Bhatt P, et al. Community-based interventions for detection and management of diabetes and hypertension in underserved communities: a mixed-methods evaluation in Brazil, India, South Africa and the USA. BMJ Global Health. 15 April 2020. doi:10.1136/ bmjgh-2019-001959.
Hulland EN, Wiens KE, Shirude S, Morgan JD, Bertozzi-Villa A, Farag TH, Fullman N, Kraemer MUG, Miller-Petrie MK, Gupta V, Reiner RC, Rabinowitz P, Wasserheit JN, Bell BP, Hay SI, Weiss DJ, Pigott DM. Travel time to health facilities in areas of outbreak potential: maps for guiding local preparedness and response. BMC Medicine. 30 December 2019. doi:10.1186/s12916-019-1459-6.
GBD 2017 Lower Respiratory Infections Collaborators. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017. The Lancet Infectious Diseases. 30 October 2019. doi:10.1016/S1473-3099(19)30410-4.
GBD 2017 Diarrhoeal Disease Collaborators. Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017. The Lancet Infectious Diseases. 30 October 2019. doi:10.1016/S1473-3099(19)30559-6.
Local Burden of Disease 2017 Child Mortality Collaborators. Mapping 123 million neonatal, infant, and child deaths between 2000 and 2017. Nature. 16 October 2019. doi:10.1038/s41586-019-1545-0.
GBD 2017 HIV Collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. The Lancet HIV. 14 August 2019. doi:10.1016/S2352-3018(19)30196-1.
Weiss DJ, Lucas TCD, Nguyen M, et al. Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study. The Lancet. 19 June 2019. doi:10.1016/S0140-6736(19)31097-9.
Battle KE, Lucas TCD, Nguyen M, et al. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study. The Lancet. 19 June 2019. doi:10.1016/S0140-6736(19)31096-7
GBD 2017 Child and Adolescent Health Collaborators. Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017. JAMA Pediatrics. 29 April 2019. doi:10.1001/jamapediatrics.2019.0337.
Global Burden of Disease Health Financing Collaborator Network. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050. The Lancet. 24 April 2019. doi: http://dx.doi.org/10.1016/S0140-6736(19)30841-4
Haakenstad A, Harle AC, Tsakalos G, Micah AE, Tao T, Anjomshoa M, Cohen J, Fullman N, Hay S, Mestrovic T, Mohammed S, Mousavi SM, Nixon MR, Pigott D, Tran K, Murray CJL, Dieleman JL. Tracking spending on malaria by source in 106 countries, 2000–16: an economic modelling study. The Lancet Infectious Disease. 24 April 2019. doi: http://dx.doi.org/10.1016/S1473-3099(19)30165-3
Mosser JF, Gagne-Maynard W, Rao PC, et al. Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000–2016: a spatial and temporal modelling study. The Lancet. 5 April 2019. doi:10.1016/S0140-6736(19)30226-0.
Moses MW, Pedroza P, Baral R, et al. Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016. The Lancet Public Health. 11 Dec 2018. doi:10.1016/S2468-2667(18)30263-9.
GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1995-2051. doi: http://dx.doi.org/10.1016/S0140-6736(18)32278-5.
GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1684-735. doi: http://dx.doi.org/10.1016/S0140-6736(18)31891-9.
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1736-88. doi: http://dx.doi.org/10.1016/S0140-6736(18)32203-7.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1789–858. doi: http://dx.doi.org/10.1016/S0140-6736(18)32279-7.
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1859–922. doi: http://dx.doi.org/10.1016/S0140-6736(18)32335-3.
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1923-94. doi: http://dx.doi.org/10.1016/S0140-6736(18)32225-6.
GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018; 392:2091–138. doi: http://dx.doi.org/10.1016/S0140-6736(18)32281-5.
Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories using data from the Global Burden of Disease Study 2016. The Lancet. 16 October 2018. doi:10.1016/S0140-6736(18)31694-5.
GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases. 19 September 2018. doi:10.1016/S1473-3099(18)30407-9.
GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases. 19 September 2018. doi:10.1016/S1473-3099(18)30424-9.
GBD 2016 Injury Collaborators. Global Mortality From Firearms, 1990-2016. JAMA. 28 Aug 2018; 320(8):792-814. doi:10.1001/jama.2018.10060.
GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 23 Aug 2018. doi:10.1016/S0140-6736(18)31310-2
GBD 2016 Greece Collaborators. The burden of disease in Greece, health loss, risk factors, and health financing, 2000–16: an analysis of the Global Burden of Disease Study 2016. The Lancet Public Health. 25 July 2018. doi:10.1016/S2468-2667(18)30130-0.
GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. The Lancet. 23 May 2018.
Global Burden of Disease Health Financing Collaborator Network. Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40. The Lancet. 17 Apr 2018.
US Burden of Disease Collaborators. The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States. JAMA. 10 April 2018; 319(14):1-33. doi:10.1001/jama.2018.0158
Osgood-Zimmerman A, Millear AI, Stubbs RW, et al. Mapping child growth failure in Africa between 2000 and 2015. Nature. 28 Feb 2018. doi:10.1038/nature25760
Graetz N, Friedman J, Osgood-Zimmerman A, et al. Mapping local variation in educational attainment across Africa. Nature. 28 Feb 2018. doi:10.1038/nature25761
Pigott DM, Deshpande A, Letourneau I, et al. Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis. The Lancet. 11 Oct 2017.
Golding N, Burstein R, Longbottom J, et al. Mapping under-5 and neonatal mortality in Africa, 2000–15: a baseline analysis for the Sustainable Development Goals. The Lancet
GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1084–1150.
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1151–210.
GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1260-344.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390; 1211–59.
GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1345-1422.
GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet. 12 Sept 2017: 390; 1423–59.
GBD 2015 LRI Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Infectious Diseases. 23 Aug 2017. doi: http://dx.doi.org/10.1016/S1473-3099(17)30396-1
Wollum A, Dansereau E, Fullman N, Achan J, Bannon KA, Burstein R, Conner RO, DeCenso B, Gasasira A, Haakenstad A, Hanlon M, Ikilezi G, Kisia C, Levine AJ, Masters SH, Njuguna P, Okiro EA, Odeny TA, Roberts DA, Gakidou E, Duber HC. The effect of facility-based antiretroviral therapy programs on outpatient services in Kenya and Uganda. BMC Health Services Research. 2017 Aug 16. doi: 10.1186/s12913-017-2512-9.
GBD Diarrheal Diseases Collaborators. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrheal diseases: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Infectious Diseases. 2017 Jun 1. http://dx.doi.org/10.1016/PII
GBD 2015 Healthcare Access and Quality Collaborators. Healthcare Access and Quality Index based on mortality from causes amenable to personal healthcare in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease 2015 study. The Lancet. 2017 May 18.
GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. The Lancet. 2017 April 7;14:48. http://dx.doi.org/10.1016/S0140-6736(17)30819-X
The Global Burden of Disease Child and Adolescent Health Collaboration. Child and adolescent health from 1990 to 2015: Findings from the Global Burden of Disease, Injuries, and Risk Factors 2015 Study. JAMA Pediatrics. 2017;171(6):1-21. doi:10.1001/jamapediatrics.2017.0250.
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1659–1724.
GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1603–1658.
GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1775–1812.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1459–1544.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1545–1602.
GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1725–1774.
Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, et al. Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2016 5 October.
Lim SS, Allen K, Bhutta ZA, et al. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. The Lancet. 2016 Sep 21. doi: 10.1016/S0140-6736(16)31467-2.
Di Giorgio L, Moses MW, Fullman N, et al. The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia. BMC Medicine. 2016 20 July. doi: 10.1186/s12916-016-0653-z.
Wang H, Wolock TM, Carter A, et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. The Lancet HIV. 2016 Jul 19. doi: 10.1016/S2352-3018(16)30087-X.
Duber HC, Roberts DA, Ikilezi G, Fullman N, Gasasira A, Gakidou G, Haakenstad A, Levine AJ, Achan J. Evaluating facility-based antiretroviral therapy program effectiveness: a pilot study comparing viral load suppression and retention rates. Tropical Medicine & Hygiene. 2016 March 21. doi: 10.1111/tmi.12694.
Ng M, Colson KE, Fullman N, Dwyer-Lindgren L, Achoki T, Schneider MT, Mulenga P, Hangoma P, Masiye F, Gakidou E. Assessing the contribution of malaria vector control and other maternal and child health interventions in reducing all-cause under-5 mortality in Zambia. American Journal of Tropical Medicine and Hygiene. 2016 Feb 15. doi: 10.4269/ajtmh.15-0315.
Di Giorgio L, Flaxman AD, Moses MW, Fullman N, Hanlon M, Conner RO, Wollum A, Murray CJL. Efficiency of health care production in low-resource settings: a Monte-Carlo simulation to compare the performance of Data Envelopment Analysis, Stochastic Distance Functions, and an ensemble model. PLOS ONE. 2016 Jan 26. doi: 10.1371/journal.pone.0147261.
Roberts DA, Ng M, Ikilezi G, Gasasira G, Dwyer-Lindgren L, Fullman N, Nalugwa T, Kamya M, Gakidou E. Benchmarking health system performance across regions in Uganda: a systematic analysis of levels and trends in key maternal and child health interventions and outcomes, 1990–2011. BMC Medicine. 2015 December 3;13(285). doi: 10.1186/s12916-015-0518-x.
Wollum A, Burstein R, Fullman N, Dwyer-Lindgren L, Gakidou E. Benchmarking health system performance across states in Nigeria: a systematic analysis of levels and trends in key maternal and child health interventions and outcomes, 2000–2013. BMC Medicine. 2015 2 September.
Colson KE, Dwyer-Lindgren L, Achoki T, Fullman N, Schneider M, Mulenga P, Hangoma P, Ng M, Masiye F, Gakidou E. Benchmarking health system performance across districts in Zambia: a systematic analysis of levels and trends in key maternal and child health interventions from 1990 to 2010. BMC Medicine. 2015 April 2. doi: 10.1186/s12916-0150308-5.
Ng M, Fullman N, Dieleman JL, Flaxman AD, Murray CJL, Lim SS. Effective coverage: a metric for monitoring universal health coverage. PLoS Medicine. 2014 Sept 22. doi: 10.1371/journal.pmed.1001730.
Fullman N, Flaxman A, Leach-Kemon K, Rajaratnam JK, Lozano R. Measuring the world’s health: How good are our estimates? In: Brown GW, Yamey G, Wamala S, eds. The Handbook of Global Health Policy. John Wiley & Sons, Ltd, 2014: 97–117.
Fullman N, Burstein R, Lim S, Medlin C, Gakidou E. Nets, spray or both? The effectiveness of insecticide-treated nets and indoor residual spraying in reducing malaria morbidity and child mortality in sub-Saharan Africa. Malaria Journal. 2013; 12:62. doi:1
Gakidou E, Fullman N. Monitoring health inequalities: measurement considerations and implications. University of Queensland: Health Information Systems Knowledge Hub. 2012 Oct; 20. http://www.uq.edu.au/hishub/docs/WP20/HISHUB-20-WP-WEB-22Oct12.pdf.
Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. Global malaria mortality between 1980 and 2010: a systematic analysis. The Lancet. 2012; 379:413-431.
Lim SS, Fullman N, Stokes A, Ravishankar N, Masiye F, Murray CJL, Gakidou E. Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Medicine. September 2011; 8(9): e1001.
Flaxman AD, Fullman N, Otten MW Jr., Menon M, Cibulskis RE, Ng M, Murray CJL, Lim SS. Rapid scaling-up of insecticide-treated bed net coverage in Africa and its relationship with development assistance for health: A systematic synthesis of supply, distribution, and household survey data. PLoS Medicine. 2010 August 17; 7(8): e1000328.
November 12, 2015
September 3, 2015
BioMed Central
July 2015 saw two big milestones for Nigeria’s quest to eliminate polio. First, the country hit the one-year mark of recording zero polio cases, a significant achievement in global health. Second, Nigeria finished introducing the inactivated polio vaccine (IPV) into routine immunization systems in five more states, accelerating the new vaccine’s implementation.
April 10, 2015
Humanosphere
The benefits of breastfeeding to the health and development of newborn children are well-documented, with ‘exclusive’ breastfeeding in the first six months of life shown to enhance children’s immunity to infectious disease
November 12, 2014
Humanosphere
“We should declare the goal of eradicating malaria because we can eradicate malaria,” Gates said, to some consternation among the malaria experts. He challenged the audience to wipe out malaria for good, as the world did with smallpox in 1980, rather than continuing to simply contain the disease.